285 related articles for article (PubMed ID: 10811866)
21. Regulation of B lymphocyte development and activation by Bruton's tyrosine kinase.
Khan WN
Immunol Res; 2001; 23(2-3):147-56. PubMed ID: 11444380
[TBL] [Abstract][Full Text] [Related]
22. Bruton's tyrosine kinase inhibition induces rewiring of proximal and distal B-cell receptor signaling in mice.
Rip J; de Bruijn MJW; Neys SFH; Singh SP; Willar J; van Hulst JAC; Hendriks RW; Corneth OBJ
Eur J Immunol; 2021 Sep; 51(9):2251-2265. PubMed ID: 34323286
[TBL] [Abstract][Full Text] [Related]
23. Transcription factor STAT5A is a substrate of Bruton's tyrosine kinase in B cells.
Mahajan S; Vassilev A; Sun N; Ozer Z; Mao C; Uckun FM
J Biol Chem; 2001 Aug; 276(33):31216-28. PubMed ID: 11413148
[TBL] [Abstract][Full Text] [Related]
24. Complementary roles for CD19 and Bruton's tyrosine kinase in B lymphocyte signal transduction.
Fujimoto M; Poe JC; Satterthwaite AB; Wahl MI; Witte ON; Tedder TF
J Immunol; 2002 Jun; 168(11):5465-76. PubMed ID: 12023340
[TBL] [Abstract][Full Text] [Related]
25. CD38 unresponsiveness of xid B cells implicates Bruton's tyrosine kinase (btk) as a regular of CD38 induced signal transduction.
Santos-Argumedo L; Lund FE; Heath AW; Solvason N; Wu WW; Grimaldi JC; Parkhouse RM; Howard M
Int Immunol; 1995 Feb; 7(2):163-70. PubMed ID: 7734414
[TBL] [Abstract][Full Text] [Related]
26. Severe B cell deficiency and disrupted splenic architecture in transgenic mice expressing the E41K mutated form of Bruton's tyrosine kinase.
Dingjan GM; Maas A; Nawijn MC; Smit L; Voerman JS; Grosveld F; Hendriks RW
EMBO J; 1998 Sep; 17(18):5309-20. PubMed ID: 9736610
[TBL] [Abstract][Full Text] [Related]
27. Dual phosphorylation of Btk by Akt/protein kinase b provides docking for 14-3-3ζ, regulates shuttling, and attenuates both tonic and induced signaling in B cells.
Mohammad DK; Nore BF; Hussain A; Gustafsson MO; Mohamed AJ; Smith CI
Mol Cell Biol; 2013 Aug; 33(16):3214-26. PubMed ID: 23754751
[TBL] [Abstract][Full Text] [Related]
28. The transcription factor Bright associates with Bruton's tyrosine kinase, the defective protein in immunodeficiency disease.
Webb CF; Yamashita Y; Ayers N; Evetts S; Paulin Y; Conley ME; Smith EA
J Immunol; 2000 Dec; 165(12):6956-65. PubMed ID: 11120822
[TBL] [Abstract][Full Text] [Related]
29. Tracking the response of Xid B cells in vivo: TI-2 antigen induces migration and proliferation but Btk is essential for terminal differentiation.
Vinuesa CG; Sunners Y; Pongracz J; Ball J; Toellner KM; Taylor D; MacLennan IC; Cook MC
Eur J Immunol; 2001 May; 31(5):1340-50. PubMed ID: 11465091
[TBL] [Abstract][Full Text] [Related]
30. Mutation of the pleckstrin homology domain of Bruton's tyrosine kinase in immunodeficiency impaired inositol 1,3,4,5-tetrakisphosphate binding capacity.
Fukuda M; Kojima T; Kabayama H; Mikoshiba K
J Biol Chem; 1996 Nov; 271(48):30303-6. PubMed ID: 8939985
[TBL] [Abstract][Full Text] [Related]
31. B-cell antigen receptor activates transcription factors NFAT (nuclear factor of activated T-cells) and NF-kappaB (nuclear factor kappaB) via a mechanism that involves diacylglycerol.
Antony P; Petro JB; Carlesso G; Shinners NP; Lowe J; Khan WN
Biochem Soc Trans; 2004 Feb; 32(Pt 1):113-5. PubMed ID: 14748726
[TBL] [Abstract][Full Text] [Related]
32. Activation of BTK by a phosphorylation mechanism initiated by SRC family kinases.
Rawlings DJ; Scharenberg AM; Park H; Wahl MI; Lin S; Kato RM; Fluckiger AC; Witte ON; Kinet JP
Science; 1996 Feb; 271(5250):822-5. PubMed ID: 8629002
[TBL] [Abstract][Full Text] [Related]
33. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes.
Thomas JD; Sideras P; Smith CI; Vorechovský I; Chapman V; Paul WE
Science; 1993 Jul; 261(5119):355-8. PubMed ID: 8332900
[TBL] [Abstract][Full Text] [Related]
34. A conditional form of Bruton's tyrosine kinase is sufficient to activate multiple downstream signaling pathways via PLC Gamma 2 in B cells.
Tomlinson MG; Woods DB; McMahon M; Wahl MI; Witte ON; Kurosaki T; Bolen JB; Johnston JA
BMC Immunol; 2001; 2():4. PubMed ID: 11410123
[TBL] [Abstract][Full Text] [Related]
35. Unimpaired activation of c-Jun NH2-terminal kinase (JNK) 1 upon CD40 stimulation in B cells of patients with X-linked agammaglobulinemia.
Brunner C; Kreth HW; Ochs HD; Schuster V
J Clin Immunol; 2002 Jul; 22(4):244-51. PubMed ID: 12148599
[TBL] [Abstract][Full Text] [Related]
36. MyD88- and Bruton's tyrosine kinase-mediated signals are essential for T cell-independent pathogen-specific IgM responses.
Alugupalli KR; Akira S; Lien E; Leong JM
J Immunol; 2007 Mar; 178(6):3740-9. PubMed ID: 17339472
[TBL] [Abstract][Full Text] [Related]
37. Activation of NF-κB in B cell receptor signaling through Bruton's tyrosine kinase-dependent phosphorylation of IκB-α.
Pontoriero M; Fiume G; Vecchio E; de Laurentiis A; Albano F; Iaccino E; Mimmi S; Pisano A; Agosti V; Giovannone E; Altobelli A; Caiazza C; Mallardo M; Scala G; Quinto I
J Mol Med (Berl); 2019 May; 97(5):675-690. PubMed ID: 30887112
[TBL] [Abstract][Full Text] [Related]
38. Synergistic B cell activation by CD40 and the B cell antigen receptor: role of B lymphocyte antigen receptor-mediated kinase activation and tumor necrosis factor receptor-associated factor regulation.
Haxhinasto SA; Bishop GA
J Biol Chem; 2004 Jan; 279(4):2575-82. PubMed ID: 14604983
[TBL] [Abstract][Full Text] [Related]
39. Bruton's tyrosine kinase is essential for hydrogen peroxide-induced calcium signaling.
Qin S; Chock PB
Biochemistry; 2001 Jul; 40(27):8085-91. PubMed ID: 11434777
[TBL] [Abstract][Full Text] [Related]
40. Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling.
Lindvall JM; Blomberg KE; Väliaho J; Vargas L; Heinonen JE; Berglöf A; Mohamed AJ; Nore BF; Vihinen M; Smith CI
Immunol Rev; 2005 Feb; 203():200-15. PubMed ID: 15661031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
